{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:28:20Z","timestamp":1773516500333,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL125303"],"award-info":[{"award-number":["R01 HL125303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL094274-10"],"award-info":[{"award-number":["T32 HL094274-10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.healun.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T11:28:03Z","timestamp":1631532483000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness and system-wide impact of using Hepatitis C-viremic donors for heart transplant"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-9938","authenticated-orcid":false,"given":"Brian","family":"Wayda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander T.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Parizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Teuteberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-5926","authenticated-orcid":false,"given":"Kiran K.","family":"Khush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.09.002_bib0001","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2017.02.010","article-title":"Addressing the growing U.S. donor heart shortage: waiting for Godot or a transplant?","volume":"69","author":"Cowger","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.healun.2021.09.002_bib0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ajt.15278","article-title":"OPTN\/SRTR 2017 annual data report: heart","volume":"19","author":"Colvin","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0003","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2017.07.756","article-title":"Traumatic brains and broken hearts: mending the donor shortage in cardiac transplantation","volume":"70","author":"Thomas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2021.09.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002679","article-title":"Matching the market for heart transplantation","volume":"9","author":"Hsich","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"Suppl 1","key":"10.1016\/j.healun.2021.09.002_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.healun.2021.09.002_bib0006","doi-asserted-by":"crossref","first-page":"e13308","DOI":"10.1111\/ctr.13308","article-title":"Accepting hepatitis C virus-infected donor hearts for transplantation: multistep consent, unrealized opportunity, and the Stanford experience","volume":"32","author":"Moayedi","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0007","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus-positive donors","volume":"38","author":"Aslam","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.healun.2021.09.002_bib0008","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.09.002_bib0009","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.healun.2021.09.002_bib0010","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/ajt.15311","article-title":"Transplanting hepatitis C virus-infected hearts into uninfected recipients: a single-arm trial","volume":"19","author":"McLean","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1016\/j.healun.2021.09.002_bib0011","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.healun.2019.08.010","article-title":"The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate","volume":"38","author":"Gernhofer","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0012","article-title":"Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients","author":"Logan","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0013","article-title":"Trends in the use of hepatitis C viremic donor hearts","author":"Li","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2021.09.002_bib0014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.healun.2019.06.023","article-title":"Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era","volume":"38","author":"Madan","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2019.11.003","article-title":"Validating thoracic simulated allocation model predictions for impact of broader geographic sharing of donor lungs on transplant waitlist outcomes","volume":"39","author":"Lehr","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10729-004-7541-3","article-title":"Simulating the allocation of organs for transplantation","volume":"7","author":"Thompson","year":"2004","journal-title":"Health Care Manag Sci"},{"key":"10.1016\/j.healun.2021.09.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.06.022","article-title":"Increased early acute cellular rejection events in hepatitis C-positive heart transplantation","author":"Gidea","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0018","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2013the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.09.002_bib0019","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.athoracsur.2017.01.055","article-title":"The paradoxical relationship between donor distance and survival after heart transplantation","volume":"103","author":"Crawford","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2021.09.002_bib0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.healun.2011.10.004","article-title":"Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation","volume":"31","author":"Weiss","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.002_bib0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MAT.0000000000001211","article-title":"Cost-effectiveness of a small intrapericardial centrifugal left ventricular assist device","volume":"66","author":"Silvestry","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2021.09.002_bib0022","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.15420\/ecr.2019.29.2","article-title":"Destination therapy with left ventricular assist devices in non-transplant centres: the time is right","volume":"15","author":"Bayes-Genis","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.healun.2021.09.002_bib0023","article-title":"Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors","volume":"zxab207","author":"Bova","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2021.09.002_bib0024","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41395-018-0033-8","article-title":"Race\/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment","volume":"113","author":"Wong","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.healun.2021.09.002_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamacardio.2020.4909","article-title":"Evolving trends in adult heart transplant with the 2018 heart allocation policy change","volume":"6","author":"Kilic","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.healun.2021.09.002_bib0026","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:41:17Z","timestamp":1760949677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821024918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1053249821024918"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.09.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness and system-wide impact of using Hepatitis C-viremic donors for heart transplant","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}